UNVERIFIEDSingle SourceSTAT+: Up and down the ladder: The latest comings and goingsStat News|11/20/2026
UNVERIFIEDSingle SourceSTAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arriveStat News|11/20/2026
UNVERIFIEDSingle SourceFDA’s search for a new leader, and China’s largest drugmakersStat News|11/20/2026
UNVERIFIEDSingle SourceSTAT+: Big drugmakers tell House committee they will halt clinical trials at some hospitals in ChinaStat News|11/20/2026
UNVERIFIEDSingle SourceSTAT+: Peptide market poised to explode with new Hims and Noom launchesStat News|11/19/2026
UNVERIFIEDSingle SourceSTAT+: Merck, Isomorphic Labs partner to develop oncology drug candidatesStat News|11/19/2026
UNVERIFIEDSingle SourceSTAT+: In cancer drug development, the spotlight shifts onto Erasca’s KRAS-targeted treatmentStat News|11/19/2026
UNVERIFIEDSingle SourceSTAT+: 7 burning questions about the FDA’s post-Overton futureStat News|11/18/2026
UNVERIFIEDSingle SourceBiodata, AI and the future of command: Getting it rightBreaking Defense|11/17/2026
UNVERIFIEDSingle SourceSTAT+: Flagship opens biotech-creation outpost in the U.K.Stat News|11/17/2026
UNVERIFIEDSingle SourceSTAT+: Sellas’ experimental blood cancer immunotherapy reduced risk of death in clinical trialStat News|11/17/2026
UNVERIFIEDSingle SourceSTAT+: With $173 million, new startup takes aim at sickle cellStat News|11/17/2026
UNVERIFIEDSingle SourceSTAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for RocheStat News|11/16/2026
UNVERIFIEDSingle SourceSTAT+: Bladder cancer immunotherapy from CG Oncology reduced risk of tumor recurrenceStat News|11/16/2026
UNVERIFIEDSingle SourceSTAT+: Versant, Lilly put $100 million behind new startup aimed at solving one of gene therapy’s thorniest issuesStat News|11/16/2026
UNVERIFIEDSingle SourceBeOne, Hengrui top list of China’s most powerful drugmakersStat News|11/16/2026
UNVERIFIEDSingle SourceSTAT+: FDA rejects lung cancer treatment ivonescimab from Summit TherapeuticsStat News|11/15/2026
UNVERIFIEDSingle SourceOpinion: U.S. dependence on China is a national security riskStat News|7/30/2026